Mckesson Corporation
MCK
Market Cap$75.1B
Close$
Earnings Call Q2 2025
November 6, 2024 - AI Summary
**Strong Financial Performance**: McKesson reported record quarterly revenue of $93.7 billion for Q2 FY2025, a 21% increase year-over-year. Adjusted operating profit grew by 7% to $1.3 billion and adjusted earnings per diluted share rose by 13% to $7.07, demonstrating robust operational execution across its segments.
**Guidance Increase**: Due to strong Q2 performance and confidence in future outlook, McKesson raised its guidance for adjusted earnings per diluted share for FY2025 to a range of $32.40 to $33.00, suggesting growth of 18% to 20% compared to FY2024.
**Sector-Specific Growth**: The U.S. Pharmaceutical segment revenue increased by 23%, driven by onboarding a new strategic partner and increased prescription volumes, particularly in specialty products and GLP-1 medications, which accounted for $10.4 billion in revenue, a 47% increase YoY.
Exclusive for Stockcircle Pro members
Sign up
$888.27
50.2% upside
Current Fair Value
50.2% upsideUndervalued by 50.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $75.10 Billion |
|---|---|
| Enterprise Value | $79.81 Billion |
| Dividend Yield | $2.84 (0.449643328036783%) |
| Earnings per Share | $22.54 |
| Beta | 0.44 |
| Outstanding Shares | 128,699,999 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 30.02 |
|---|---|
| PEG | 54.62 |
| Price to Sales | 0.23 |
| Price to Book Ratio | 13.44 |
| Enterprise Value to Revenue | 0.24 |
| Enterprise Value to EBIT | 23.34 |
| Enterprise Value to Net Income | 24 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 1.27 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Mckesson Corporation
80,000 employees
CEO: Brian Tyler McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. McKesson partners with pharmaceutical manufacturers, p...